Search Results - "Zharkova, N B"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
  2. 2

    mGlu2/3 Agonists – a New Approach to the Treatment of Schizophrenia: Results of a Randomized Double-Blind Trial by Mosolov, S. N., Smulevich, A. B., Neznanov, N. G., Tochilov, V. A., Andreev, B. V., Avedisova, A. S., Bardenstein, L. M., Gurovich, I. Ya, Reznik, A. M., Zharkova, N. B., Martenyi, F.

    Published in Neuroscience and behavioral physiology (01-07-2011)
    “…Anomalies in glutamatergic neurotransmission are currently believed to be one of the pathogenetic factors in schizophrenia and dopamine antagonists are…”
    Get full text
    Journal Article
  3. 3

    The use of mGlu2/3 receptors as a new approach to treat schizophrenia: results of a randomized double-blind trial by Mosolov, S N, Smulevich, A B, Neznanov, N G, Tochilov, V A, Andreev, B V, Avedisova, A S, Bardenshteĭn, L M, Gurovich, I Ia, Reznik, A M, Zharkova, N B, Martenyi, F

    “…Glutamate neurotransmission has been considered as one of pathogenetic factors of schizophrenia though all antipsychotics widely used in modern psychiatric…”
    Get more information
    Journal Article
  4. 4

    The experience of application of olanzapine: an atypical neuroleptic in acute schizophrenia by Morozova, M A, Zharkova, N B, Beniashvili, A G

    “…Thirty adult patients with acute schizophrenia were included into six-week open-labelled, non-comparative trial of olanzapine with free dosing from 5 to 20 mg…”
    Get more information
    Journal Article
  5. 5

    Characteristics of the premanifest period of late schizophrenia with the picture of an involutional paranoid by Zharkova, N B

    “…Study of the premanifest period in 65 patients with schizophrenia that first manifested in old age by the "involutional paranoid" syndrome demonstrated that…”
    Get more information
    Journal Article
  6. 6